Nestlé Builds a Brazil Formula Plant to Cut Chile Imports

Nestlé will spend R$600 million on a second infant-formula factory in Ituiutaba, Minas Gerais, with output due in the second quarter of 2028. The plant sits next to the company’s largest dairy complex in Latin America, where Ninho and Molico powder already run.

On September 3, 2026, Nestlé Brasil folded that factory into an R$2 billion nutrition and health plan through 2028 ($392.73 million). Jeff Hamilton, who runs Nestlé’s Americas business, called Brazil a strategic market for the category and said the spend would expand local production. The more specific problem is smaller: a slice of Brazilian demand still arrives from Chile.

The New Plant Sits on Nestlé’s Dairy Campus

Ituiutaba already houses Nestlé’s biggest dairy operation in Latin America. Marcelo Melchior, CEO of Nestlé Brazil, said putting formula on the same site lets the new plant share electricity, steam and water instead of paying for a greenfield grid. Construction is due to start in 2027. About 700 people are expected on the build; about 100 direct jobs stay once the lines run.

Nestlé Global billed the same nutrition package at CHF 310 million. Nestlé Brasil said that package is about 30 percent of the R$7 billion the company has marked for Brazil between 2025 and 2028. The Ituiutaba factory is the headline project inside that bag, and it is the group’s second infant-nutrition plant in the country.

THE NUTRITION SITES IN THE 2028 PLAN

The new block is due to use biomethane in boilers and ovens, in line with a wider switch away from liquefied petroleum gas at Nestlé’s Minas Gerais dairy sites. Nestlé already counts 18 operating factories and 12 distribution centres in Brazil.

Chile Has Been Covering a Capacity Gap

Melchior was blunt about why a company that already dominates baby milk still needs another plant. Brazil’s lines could not cover the whole book, so a small portion of formula has been coming from abroad, mainly from Chile. He said the company does not spend in order to export, and that surplus for other countries would be a byproduct if it appears.

We were constrained by production capacity, so we had to bring in a small portion from abroad, mainly from Chile. Now we’re going in the opposite direction. We may be able to export some surplus.

Marcelo Melchior, CEO, Nestlé Brazil

Marcelo Citrangulo, Nestlé Brazil’s nutrition chief, put the same shift in plainer terms: the core of the spend is that the company stops importing and starts exporting. Until the Minas Gerais lines open, that Chile volume still has a job. After 2028, the Ituiutaba campus is supposed to feed Brazil first and then, if powder is left over, other markets Nestlé has not named in public.

Four Brands Will Run on the First Lines

The plant is rated at 40,000 tonnes a year. First output is not the specialty amino-acid tin that Anvisa pulled in February. It is the mass brands already on Brazilian shelves, including growing-up milks sold under Ninho.

THE FIRST FOUR LINES

• Nestogeno: Infant formula listed by Nestlé for the opening mix at Ituiutaba.
• Nestonutri: A second infant-nutrition brand named for the same start-up set.
• Ninho 1+: Growing-up milk from the powder brand already made at the dairy next door.
• Ninho 3+: The older-toddler Ninho SKU named for the same first wave.

Nan and Lactogen remain in the Brazilian book, but they are not on the opening list Nestlé issued with the plant. The factory is a volume play on names the company already sells into a market it already leads, with the dairy campus next door supplying milk powder and utilities.

Carazinho Whey Already Feeds Most Formulas

Finished tins are only half of the localization. In March 2026 Nestlé took back a whey plant in Carazinho, Rio Grande do Sul, after five years away, and spent more than R$60 million to restart it. Citrangulo said whey from that site is in about 90 percent of the nutrition portfolio made in Brazil. Nestlé said it would raise whey output 15% by 2029.

Whey is the protein fraction left when milk is set for cheese, and it is a standard building block in infant formula. Pulling that input back under Nestlé’s own roof cuts a supplier step in a year when an oil blend, not milk, was the ingredient that forced global recalls. Carazinho is not a baby-milk factory. It is the ingredient plant that makes the Ituiutaba and Araçatuba recipe less exposed to someone else’s tank.

The 15 percent whey lift is timed to 2029, a year after Ituiutaba is due to start. That is the quiet clock inside the announcement: more local powder, then more local protein, on a campus that already makes Ninho.

Brazil Recorded 2.38 Million Births in 2024

GlobalData put Brazilian baby-milk sales at 2.53 billion reais in 2025 and sees 2.9 billion reais by 2029, a 3.6 percent compound annual rate. In that book Nestlé held an 80.9 percent share last year. Those are not the numbers of a company fighting for a foothold. They are the numbers of an incumbent adding capacity.

BRAZIL BABY MILK IN ONE LOOK

• Nestlé share, 2025: 80.9 percent of baby milk, per GlobalData.
• Category sales, 2025: 2.53 billion reais, with 2.9 billion reais forecast for 2029.
• Growth rate: 3.6 percent a year through 2029, still a slow climb.
• Live births, 2024: 2.38 million, down 5.8 percent from 2023 and the sixth straight annual drop, according to IBGE.

Melchior said the drop in births is slow and will run for decades, and that infant nutrition still has work because eating habits set in the first 1,000 days. Citrangulo said the company’s job is also to push back on the wrong foods in the first year of life. Neither man described a boom. Euromonitor’s baby-food read for Brazil still puts Nestlé and Danone as the two names that account for most sales, which leaves little room for a third factory to be about share gain.

In Brazilian discussion the plant was quickly used as a scorecard for whether industry is staying in the country. The industrial reason is narrower. Nestlé is adding tonnes in a category it already owns, while the birth count heads the other way, because the constraint it named is Chilean backfill, not empty shelves.

The Revenue Hub Is Still in São Paulo State

Araçatuba, further south, remains the money engine. Nestlé calls it the main hub in Brazil for infant, medical and adult nutrition, and on July 20, 2026 the company said it would put R$540 million into that factory through 2028. The site makes more than 180 products, employs about 800 people directly and about 200 indirectly, and already ships some volume to Latin America and the Middle East.

Each infant formula leaving Araçatuba, Nestlé said, goes through about 1,200 tests, and each milk tanker gets more than 20 checks before it enters the plant. That is the factory the new Minas Gerais lines will sit behind, not replace. Ituiutaba adds standard formula tonnes on a dairy campus. Araçatuba keeps the wider nutrition book, including medical SKUs the new plant is not scheduled to make on day one.

Citrangulo has said the larger white space inside the R$2 billion bag is adult nutrition, where Nestlé’s share is still below its other platforms. Whey protein and similar products have been selling faster in Brazilian retail this year, but that is a different aisle from Nestogeno. The Ituiutaba decision should be read as a baby-milk supply move, paid for inside a nutrition budget that also has older consumers in view.

Anvisa Pulled Ten Alfamino Batches in February

The factory news landed seven months after Brazil’s health regulator ordered a recall of ten Alfamino batches. Anvisa’s February 12, 2026 notice said tests on Alfamino 400g showed about 31.1 mcg of selenium per 100 kcal and about 175.7 mcg of iodine per 100 kcal, above the limits for formulas aimed at infants and young children. Sale, distribution, import, advertising and use of those lots were suspended.

Anvisa warned that extra selenium can bring nausea, vomiting, diarrhea, irritability and hair loss, and that extra iodine can affect weight gain, the thyroid and growth. Nestlé said it was surprised by the order and that a conversion error in a lab report (mcg/kg written where mcg/100g belonged) had produced the high figures. The company said the correct values were 3.11 mcg of selenium and 17.57 mcg of iodine per 100 kcal, inside the rules, and that the tins were safe. Alfamino is an amino-acid formula for babies who cannot take cow’s-milk protein. It is not on the Ituiutaba start-up list.

THE FORMULA YEAR BEFORE THE ANNOUNCEMENT

1. December 10, 2025: Nestlé starts a precautionary public recall in 16 European countries after cereulide, a toxin linked to Bacillus cereus, is found in samples from a Netherlands plant.
2. December 23, 2025: Tests point to an arachidonic acid oil blend from a global supplier used in several factories.
3. January 5, 2026: The recall widens beyond Europe; SMA, Guigoz, Nidal and other brands are named in national notices.
4. January 7, 2026: Nestlé Brasil opens a voluntary, preventive recall of listed infant-formula lots after cereulide is flagged in an ingredient, and says no confirmed illness has been reported to the company.
5. February 12, 2026: Anvisa orders the ten Alfamino 400g lots off the Brazilian market over selenium and iodine; Nestlé disputes the figures as a unit error.
6. July 20, 2026: Nestlé commits R$540 million to Araçatuba through 2028.
7. September 3, 2026: Nestlé names the R$600 million Ituiutaba formula plant and the R$2 billion nutrition package.

Cereulide and the Alfamino minerals order are separate files. One began with an oil blend in Europe. The other is a Brazilian dispute over a lab unit. Nestlé now says it runs systematic cereulide tests on oil mixes used in infant formula. It did not present the Minas Gerais factory as a reply to either case. The sequence still sits on the same calendar: a year of pulled tins, then a second Brazilian formula plant designed to take volume off a Chilean line.

Hamilton’s line about access to science-based nutrition is the global gloss. On the ground the plant is a 40,000-tonne annex to a dairy campus Nestlé already runs, paid for inside a nutrition budget that is about 30 percent of the company’s Brazil spend through 2028. Production is due in the second quarter of 2028. Until those lines run, a portion of the country’s Nestlé formula still comes in from Chile.